• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心肌病中症状性心肌缺血对强化血管扩张剂治疗的反应。

Response of symptomatic myocardial ischemia in ischemic cardiomyopathy to intensive vasodilator therapy.

作者信息

Levine T B, Levine A B, Vincenzi A, Keteyian S J, Billings J, Lesch M

机构信息

Division of Cardiology, Henry Ford Hospital, Detroit, Michigan 48202, USA.

出版信息

Am J Cardiol. 1997 Jul 15;80(2):212-4. doi: 10.1016/s0002-9149(97)00322-6.

DOI:10.1016/s0002-9149(97)00322-6
PMID:9230164
Abstract

To determine the cardiovascular protective effects of angiotensin-converting enzyme inhibitors, we examined the response to intensive vasodilator therapy in patients with ischemic cardiomyopathy and ongoing angina pectoris. We found that for patients with ischemic cardiomyopathy and ongoing active angina, intensive vasodilator therapy with angiotensin-converting enzyme inhibition and nitrates improved not only heart failure-related symptoms, but also resulted in a significant improvement in symptomatic ischemia and ischemia-related morbid events.

摘要

为了确定血管紧张素转换酶抑制剂对心血管的保护作用,我们研究了缺血性心肌病和持续性心绞痛患者对强化血管扩张剂治疗的反应。我们发现,对于患有缺血性心肌病和持续性活动性心绞痛的患者,采用血管紧张素转换酶抑制和硝酸盐进行强化血管扩张剂治疗不仅改善了与心力衰竭相关的症状,而且还显著改善了症状性缺血和与缺血相关的不良事件。

相似文献

1
Response of symptomatic myocardial ischemia in ischemic cardiomyopathy to intensive vasodilator therapy.缺血性心肌病中症状性心肌缺血对强化血管扩张剂治疗的反应。
Am J Cardiol. 1997 Jul 15;80(2):212-4. doi: 10.1016/s0002-9149(97)00322-6.
2
[Use of isosorbide dinitrate and antagonists of angiotensin II in patients with stable angina pectoris in early stages of cardiac insufficiency].[硝酸异山梨酯与血管紧张素 II 拮抗剂在心脏功能不全早期稳定型心绞痛患者中的应用]
Lik Sprava. 2001 Mar-Apr(2):146-8.
3
Reverse remodeling in heart failure with intensification of vasodilator therapy.心力衰竭中血管扩张剂强化治疗的逆向重构。
Clin Cardiol. 1997 Aug;20(8):697-702. doi: 10.1002/clc.4960200806.
4
Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment.血管紧张素转换酶抑制剂阿拉普利对慢性硝酸异山梨酯治疗期间稳定型劳力性心绞痛患者的影响。
Am J Cardiol. 1996 Jun 1;77(14):1159-63. doi: 10.1016/s0002-9149(96)00155-5.
5
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.心力衰竭治疗反应中的种族差异:血管扩张剂治疗心力衰竭试验分析。血管扩张剂治疗心力衰竭试验研究组
J Card Fail. 1999 Sep;5(3):178-87. doi: 10.1016/s1071-9164(99)90001-5.
6
[Anti-ischemic efficacy of combination of trimetazidine with enalapril in patients with stable effort angina and metabolic syndrome].曲美他嗪与依那普利联合应用于稳定型劳力性心绞痛合并代谢综合征患者的抗缺血疗效
Kardiologiia. 2005;45(8):17-22.
7
Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.第三次血管扩张剂-心力衰竭试验(V-HeFT III)的原理与设计:非洛地平作为依那普利和袢利尿剂的辅助治疗药物,用于慢性充血性心力衰竭患者,联合或不联合地高辛。V-HeFT III研究人员
Am J Cardiol. 1996 May 15;77(12):1078-82. doi: 10.1016/s0002-9149(96)00136-1.
8
Race-based therapeutics.基于种族的疗法。
N Engl J Med. 2004 Nov 11;351(20):2035-7. doi: 10.1056/NEJMp048271. Epub 2004 Nov 8.
9
Ineffectiveness of angiotensin converting enzyme inhibition (enalapril) on overt and silent myocardial ischemia in vasospastic angina and comparison with verapamil.血管紧张素转换酶抑制剂(依那普利)对变异性心绞痛明显和隐匿性心肌缺血的无效性及与维拉帕米的比较
Clin Pharmacol Ther. 1996 Apr;59(4):476-81. doi: 10.1016/S0009-9236(96)90118-6.
10
[Nitrates. The place in contemporary therapy of ischemic heart disease].[硝酸盐类。在当代缺血性心脏病治疗中的地位]
Kardiologiia. 2005;45(7):69-72.

引用本文的文献

1
Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study.尽管接受了最佳药物治疗和血运重建治疗,仍有持续性胸痛或呼吸困难的缺血性心肌病患者使用雷诺嗪与安慰剂的对比:随机、双盲交叉试验研究
Ther Clin Risk Manag. 2015 Mar 23;11:469-74. doi: 10.2147/TCRM.S82288. eCollection 2015.